Australia and New Zealand / Product Areas / Vascular Access / Central Access / Long-Term Central Venous Catheters (JACC)

Only available in New Zealand

Arrowg+ard Blue Advance JACC

The first and only long-term antimicrobial* and antithrombogenic** CVC.

 

The Arrowg+ard Blue Advance Jugular Axillo-Subclavian Central Catheter (JACC) is ideal for both short-term and long-term dwell needs of your complicated patients. This antimicrobial and antithrombogenic CVC can stay with the patient for their entire length of therapy, from ICU to Outpatient Care.

 

View this product in our Product Catalog



 

References:

  1. Rosenbauer KA, Herzer JA. Surface morphology and tensile force at breaking point or different kinds of intravenous catheters before and after usage. Scan Electron Microsc. 1981;(Pt 3):125-30.
  2. Collins JL, Lutz RJ. In vitro Study of Simultaneous Infusion of Incompatible Drugs in Multilumen Catheters. Heart & Lung. 1991; 20(3):271-7.
Rx only

Contraindication:
The Arrowg+ard Blue Advance JACC is contraindicated for patients with known hypersensitivity to chlorhexidine.

*In vitro data on file 2010. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

** As compared to uncoated PICCs, intravascular ovine model inoculated with Staph aureus. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, and Blue FlexTip are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MCI-2020-0428